Your browser doesn't support javascript.
loading
Research progress on caffeine citrate in the treatment of neonatal respiratory distress syndrome / 中国小儿急救医学
Article em Zh | WPRIM | ID: wpr-955123
Biblioteca responsável: WPRO
ABSTRACT
Neonatal respiratory distress syndrome is typically characterized by progressive exacerbation of respiratory distress shortly after birth, which is more common in preterm infants and has a high disability and mortality rate.Caffeine citrate has been used in the treatment of premature infants with respiratory distress syndrome to enhance the contraction of the diaphragm and optimize the function of respiratory muscles to accelerate the recovery of spontaneous breathing.This review summarized the use of caffeine citrate in premature infants with respiratory distress syndrome.
Palavras-chave
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: Chinese Pediatric Emergency Medicine Ano de publicação: 2022 Tipo de documento: Article
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: Chinese Pediatric Emergency Medicine Ano de publicação: 2022 Tipo de documento: Article